66 related articles for article (PubMed ID: 23267986)
1. [Changes in myeloid-derived suppressor cells in malignant effusions of cancer patients following cancer chemotherapy].
Gonda K; Shibata M; Shimura T; Abe N; Suzuki S; Yasuda M; Nakamura I; Ohtake T; Ohki S; Watanabe T; Fujimori K; Suzuki S; Ohto H; Takenoshita S
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2088-91. PubMed ID: 23267986
[TBL] [Abstract][Full Text] [Related]
2. Circulating myeloid-derived suppressor cells are increased and correlate to immune suppression, inflammation and hypoproteinemia in patients with cancer.
Ohki S; Shibata M; Gonda K; Machida T; Shimura T; Nakamura I; Ohtake T; Koyama Y; Suzuki S; Ohto H; Takenoshita S
Oncol Rep; 2012 Aug; 28(2):453-8. PubMed ID: 22614133
[TBL] [Abstract][Full Text] [Related]
3. [Myeloid-derived suppressor cells in patients with breast cancer].
Gonda K; Shibata M; Ohtake T; Yasuda M; Abe N; Watanabe K; Ando J; Okano M; Onozawa H; Tachibana K; Ohto H; Takenoshita S
Gan To Kagaku Ryoho; 2012 Sep; 39(9):1363-8. PubMed ID: 22996770
[TBL] [Abstract][Full Text] [Related]
4. [Myeloid-derived suppressor cells in cancer patients].
Gonda K; Shibata M; Nakamura I; Kenjo A; Ohtake T; Yasuda M; Suzuki S; Suzuki H; Watanabe T; Fujimori K; Gotoh M; Takenoshita S
Gan To Kagaku Ryoho; 2012 Nov; 39(12):1797-9. PubMed ID: 23267890
[TBL] [Abstract][Full Text] [Related]
5. Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8/A9 proinflammatory proteins.
Wang L; Chang EW; Wong SC; Ong SM; Chong DQ; Ling KL
J Immunol; 2013 Jan; 190(2):794-804. PubMed ID: 23248262
[TBL] [Abstract][Full Text] [Related]
6. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
[TBL] [Abstract][Full Text] [Related]
7. Phenotypes, accumulation, and functions of myeloid-derived suppressor cells and associated treatment strategies in cancer patients.
Jiang J; Guo W; Liang X
Hum Immunol; 2014 Nov; 75(11):1128-37. PubMed ID: 25305034
[TBL] [Abstract][Full Text] [Related]
8. Contribution of myeloid-derived suppressor cells to tumor-induced immune suppression, angiogenesis, invasion and metastasis.
Ye XZ; Yu SC; Bian XW
J Genet Genomics; 2010 Jul; 37(7):423-30. PubMed ID: 20659706
[TBL] [Abstract][Full Text] [Related]
9. Triggering receptor expressed on myeloid cells-1 in pleural effusions: a marker of inflammatory disease.
Liu CL; Hsieh WY; Wu CL; Kuo HT; Lu YT
Respir Med; 2007 May; 101(5):903-9. PubMed ID: 17097866
[TBL] [Abstract][Full Text] [Related]
10. Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease.
Rieber N; Brand A; Hector A; Graepler-Mainka U; Ost M; Schäfer I; Wecker I; Neri D; Wirth A; Mays L; Zundel S; Fuchs J; Handgretinger R; Stern M; Hogardt M; Döring G; Riethmüller J; Kormann M; Hartl D
J Immunol; 2013 Feb; 190(3):1276-84. PubMed ID: 23277486
[TBL] [Abstract][Full Text] [Related]
11. Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.
Schlecker E; Stojanovic A; Eisen C; Quack C; Falk CS; Umansky V; Cerwenka A
J Immunol; 2012 Dec; 189(12):5602-11. PubMed ID: 23152559
[TBL] [Abstract][Full Text] [Related]
12. [Intrapleural transfer of LAK cells combined with rIL-2 in the treatment of advanced lung cancer with malignant pleural effusion].
Li DJ
Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):294-6. PubMed ID: 2625114
[TBL] [Abstract][Full Text] [Related]
13. Myeloid derived suppressor cells and their role in tolerance induction in cancer.
Fujimura T; Mahnke K; Enk AH
J Dermatol Sci; 2010 Jul; 59(1):1-6. PubMed ID: 20570112
[TBL] [Abstract][Full Text] [Related]
14. Amino acid metabolism related to immune tolerance by MDSCs.
Yang B; Wang X; Ren X
Int Rev Immunol; 2012 Jun; 31(3):177-83. PubMed ID: 22587019
[TBL] [Abstract][Full Text] [Related]
15. ¹⁸F-fluorodeoxyglucose PET/CT findings in pleural effusions of patients with known cancer. A cytopathological correlation.
Letovanec I; Allenbach G; Mihaescu A; Nicod Lalonde M; Schmidt S; Stupp R; Fitting JW; Boubaker A; Ris HB; Prior JO
Nuklearmedizin; 2012; 51(5):186-93. PubMed ID: 22584348
[TBL] [Abstract][Full Text] [Related]
16. Myeloid-derived suppressor cells--their role in haemato-oncological malignancies and other cancers and possible implications for therapy.
Tadmor T; Attias D; Polliack A
Br J Haematol; 2011 Jun; 153(5):557-67. PubMed ID: 21477210
[TBL] [Abstract][Full Text] [Related]
17. IFN-γ producing T cells contribute to the increase of myeloid derived suppressor cells in tumor-bearing mice after cyclophosphamide treatment.
Guo Q; Lv Z; Fu Q; Jiang C; Liu Y; Lai L; Chen Q; Shen J; Wang Q
Int Immunopharmacol; 2012 Feb; 12(2):425-32. PubMed ID: 22226750
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
[TBL] [Abstract][Full Text] [Related]
19. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.
Haile LA; von Wasielewski R; Gamrekelashvili J; Krüger C; Bachmann O; Westendorf AM; Buer J; Liblau R; Manns MP; Korangy F; Greten TF
Gastroenterology; 2008 Sep; 135(3):871-81, 881.e1-5. PubMed ID: 18674538
[TBL] [Abstract][Full Text] [Related]
20. Functional changes in myeloid-derived suppressor cells (MDSCs) during tumor growth: FKBP51 contributes to the regulation of the immunosuppressive function of MDSCs.
Kim YS; Kim YJ; Lee JM; Kim EK; Park YJ; Choe SK; Ko HJ; Kang CY
J Immunol; 2012 May; 188(9):4226-34. PubMed ID: 22474024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
